MicroRNA 21-mediated suppression of sprouty1 by Pokemon affects liver cancer cell growth and proliferation

Journal of Cellular Biochemistry

Volumn 114, Issue 7, 2013, Pages 1625-1633

  Jin, Xiu Li ^a,b   Sun, Qin Sheng ^a   Liu, Feng ^a   Yang, Hong Wei ^a   Liu, Min ^a   Liu, Hong Xia ^a,b   Xu, Wei ^b   Jiang, Yu Yang ^a,c  

^a TSINGHUA UNIVERSITY   (China)

^b SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^c Tsinghua University   (China)

Author keywords

LIVER CANCER; microRNA 21; POKEMON; siRNA; Sprouty1

Indexed keywords

BETA ACTIN; MESSENGER RNA; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; ONCOPROTEIN; POKEMON PROTEIN; SPROUTY1 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL GROWTH; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; GENE EXPRESSION; LIVER CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; SITE DIRECTED MUTAGENESIS; UPREGULATION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MEMBRANE PROTEINS; MICRORNAS; MUTAGENESIS, SITE-DIRECTED; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 84877710459     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24504     Document Type: Article

References (42)

1. Aggarwal A, Hunter WJ III, Aggarwal H, Silva ED, Davey MS, Murphy RF, Agrawal DK,. 2010. Expression of leukemia/lymphoma-related factor (LRF/POKEMON) in human breast carcinoma and other cancers. Exp Mol Pathol 89: 140-148.
2. Apostolopoulou K, Pateras I, Evangelou K, Tsantoulis P, Liontos M, Kittas C, Tiniakos D, Kotsinas A, Cordon-Cardo C, Gorgoulis V,. 2007. Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer. J Pathol 213: 294-302. (Pubitemid 350074019)
3. Asangani I, Rasheed S, Nikolova D, Leupold J, Colburn N, Post S, Allgayer H,. 2007. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 27: 2128-2136. (Pubitemid 351485639)
4. Bartel DP,. 2004. MicroRNAs: Genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
5. Bartel DP,. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
6. Casci T, Vinõs J, Freeman M,. 1999. Sprouty, an intracellular inhibitor of Ras signaling. Cell 96: 655-665. (Pubitemid 29122808)
7. Chan JA, Krichevsky AM, Kosik KS,. 2005. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res 65: 6029.
8. Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB,. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat Genet 33: 197-202. (Pubitemid 36177074)
9. Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA,. 2006. Endotoxin-induced down-regulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J Immunol 176: 2414.
10. Davies J, Hawe N, Kabarowski J, Huang Q, Zhu J, Brand N, Leprince D, Dhordain P, Cook M, Morriss-Kay G,. 1999. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene. Oncogene 18: 365.
11. Fong CW, Chua MS, McKie AB, Ling SHM, Mason V, Li R, Yusoff P, Lo TL, Leung HY, So SKS,. 2006. Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. Cancer Res 66: 2048.
12. Hacohen N, Kramer S, Sutherland D, Hiromi Y, Krasnow MA,. 1998. sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell 92: 253-263. (Pubitemid 28073048)
13. Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, Van Rooij E, Olson EN,. 2010. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293.
14. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ,. 2005. A microRNA polycistron as a potential human oncogene. Nature 435: 828-833. (Pubitemid 40839734)
15. Iorio MV, Visone R, Di Leva G, Donati V, Petrocca F, Casalini P, Taccioli C, Volinia S, Liu CG, Alder H,. 2007. MicroRNA signatures in human ovarian cancer. Cancer Res 67: 8699.
16. Jeon BN, Yoo JY, Choi WI, Lee CE, Yoon HG, Hur MW,. 2008. Proto-oncogene FBI-1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of co-repressors. J Biol Chem 283: 33199-33210.
17. Kim VN,. 2005. MicroRNA biogenesis: Coordinated cropping and dicing. Nat Rev Mol Cell Biol 6: 376-385. (Pubitemid 40637855)
18. Kramer S, Okabe M, Hacohen N, Krasnow MA, Hiromi Y,. 1999. Sprouty: A common antagonist of FGF and EGF signaling pathways in Drosophila. Development 126: 2515-2525. (Pubitemid 29299020)
19. Kukita A, Kukita T, Ouchida M, Maeda H, Yatsuki H, Kohashi O,. 1999. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis. Blood 94: 1987-1997. (Pubitemid 29430415)
20. Kwabi-Addo B, Wang J, Erdem H, Vaid A, Castro P, Ayala G, Ittmann M,. 2004. The expression of Sprouty1, an inhibitor of fibroblast growth factor signal transduction, is decreased in human prostate cancer. Cancer Res 64: 4728.
21. Lo TL, Yusoff P, Fong CW, Guo K, McCaw BJ, Phillips WA, Yang H, Wong ESM, Leong HF, Zeng Q,. 2004. The ras/mitogen-activated protein kinase pathway inhibitor and likely tumor suppressor proteins, sprouty 1 and sprouty 2 are deregulated in breast cancer. Cancer Res 64: 6127-6136. (Pubitemid 39129413)
22. Maeda T, Hobbs RM, Merghoub T, Guernah I, Zelent A, Cordon-Cardo C, Teruya-Feldstein J, Pandolfi PP,. 2005a. Role of the proto-oncogene Pokemon in cellular transformation and ARF repression. Nature 433: 278-285.
23. Maeda T, Hobbs RM, Pandolfi PP,. 2005b. The transcription factor Pokemon: A new key player in cancer pathogenesis. Cancer Res 65: 8575.
24. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T,. 2007. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658. (Pubitemid 47187346)
25. Morrison DJ, Pendergrast PS, Stavropoulos P, Colmenares SU, Kobayashi R, Hernandez N,. 1999. FBI-1, a factor that binds to the HIV-1 inducer of short transcripts (IST), is a POZ domain protein. Nucleic Acids Res 27: 1251.
26. Mraz M, Pospisilova S, Malinova K, Slapak I, Mayer J,. 2009. MicroRNAs in chronic lymphocytic leukemia pathogenesis and disease subtypes. Leuk Lymphoma 50: 506-509.
27. Pessler F, Pendergrast PS, Hernandez N,. 1997. Purification and characterization of FBI-1, a cellular factor that binds to the human immunodeficiency virus type 1 inducer of short transcripts. Mol Cell Biol 17: 3786.
28. Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A, Mariani L, Cremisi F, Rainaldi G,. 2009. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics 39: 210-218.
29. Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A, Rizzo M, Evangelista M, Mercatanti A, Pandolfi PP,. 2008. The proto-oncogene LRF is under post-transcriptional control of MiR-20a: Implications for senescence. PLoS ONE 3: e2542.
30. Reich A, Sapir A, Shilo B,. 1999. Sprouty is a general inhibitor of receptor tyrosine kinase signaling. Development 126: 4139.
31. Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, Yan L, Malhotra A, Vatner D, Abdellatif M,. 2008. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell 19: 3272-3282.
32. Schubot FD, Tropea JE, Waugh DS,. 2006. Structure of the POZ domain of human LRF, a master regulator of oncogenesis. Biochem Biophys Res Commun 351: 1-6. (Pubitemid 44635398)
33. Shalgi R, Lieber D, Oren M, Pilpel Y,. 2007. Global and local architecture of the mammalian microRNA-transcription factor regulatory network. PLoS Comput Biol 3: e131.
34. Si M, Zhu S, Wu H, Lu Z, Wu F, Mo Y,. 2006. miR-21-mediated tumor growth. Oncogene 26: 2799-2803. (Pubitemid 46663837)
35. Thum T, Gross C, Fiedler J, Fischer T, Kissler S, Bussen M, Galuppo P, Just S, Rottbauer W, Frantz S,. 2008. MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts. Nature 456: 980-984.
36. Verduci L, Simili M, Rizzo M, Mercatanti A, Evangelista M, Mariani L, Rainaldi G, Pitto L,. 2010. MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis. J Biol Chem 285: 39551.
37. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M,. 2006. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103: 2257-22261.
38. Wei CL, Wu Q, Vega VB, Chiu KP, Ng P, Zhang T, Shahab A, Yong HC, Fu YT, Weng Z,. 2006. A global map of p53 transcription-factor binding sites in the human genome. Cell 124: 207-219. (Pubitemid 43069320)
39. Yu X, Lin J, Zack DJ, Mendell JT, Qian J,. 2008. Analysis of regulatory network topology reveals functionally distinct classes of microRNAs. Nucleic Acids Res 36: 6494-6503.
40. Zhu S, Si ML, Wu H, Mo YY,. 2007. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328.
41. Zu X, Yu L, Sun Q, Liu F, Wang J, Xie Z, Wang Y, Xu W, Jiang Y,. 2009. SP1 enhances Zbtb7A gene expression via direct binding to GC box in HePG2 cells. BMC Res Notes 2: 175.
42. Zu X, Ma J, Liu H, Liu F, Tan C, Yu L, Wang J, Xie Z, Cao D, Jiang Y,. 2011. Pro-oncogene Pokemon promotes breast cancer progression by upregulating survivin expression. Breast Cancer Res 13: R26.